By InvitationNot Applicable

Incidence of Bleeding on Probing as an Indicator of Peri-Implant Disease Progression

United States150 participantsStarted 2023-09-11

Plain-language summary

The primary goal of the present prospective cohort study is to evaluate the effect of varying incidences of BOP at implant sites across 15 months of maintenance visits on the probability of peri-implant disease progression. Over 15 months, participants will attend 6 visits where clinical measurements and maintenance care will be performed every 3 months.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: To be enrolled in the study, the participant must meet the following inclusion criteria: * adults in good general health (at least ASA 2) * having ≥ 1 dental implant that was restored before January 2021 * patients of the University of Pittsburgh Periodontics Department * available for maintenance visits every 3 months for the length of the study Exclusion Criteria: * Active infectious diseases of any kind * Pregnant or planning to become pregnant (self-reported) * Congenital or metabolic bone disorders * Current heavy smokers: Subjects who have smoked more than 1 pack/day within 6 months of study onset * Co-morbid conditions that would affect the study outcome or interpretation of study results * Require treatment for periodontal disease prior to baseline

What they're measuring

Marginal Bone Loss (MBL)

Timeframe: Baseline and 15 months

Trial details

NCT IDNCT06033859

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-12

View on ClinicalTrials.gov More Peri-Implantitis trials